ATTBF.US Abattis Bioceuticals Corp

Healthcare Pharmaceuticals USA Stocks
0.0000 USD
Close of Nov 13, 2026
Market cap
USD 14.3K
P/E
-
P/B
0.38x
ROE
-27.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2019.

Is ATTBF.US undervalued?

Graham number

The Graham number of Abattis Bioceuticals Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Abattis Bioceuticals Corp fundamental analysis

No fundamental analysis for Abattis Bioceuticals Corp yet.

Abattis Bioceuticals Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Abattis Bioceuticals Corp

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation an…

Full company profile